The European Atherosclerosis Society (EAS) will be holding their 83rd EAS Congress in Glasgow, UK, from March 22-25, 2015, in partnership with the British Atherosclerosis Society. The Congress brings together clinicians and basic scientists from across a range of disciplines in order to present novel insights on future challenges in atherosclerosis, spark scientific creativity, and stimulate collaboration.
Stacey Lane, a member of the FHF’s Board of Directors, will be in attendance. She is also presenting during the FH Patient Advocacy Group Representative Meeting in Glasgow on Saturday, March 21, before the start of the EAS Congress.
More information regarding EAS 2015 may be found here: www.eas-society.org/eas-2015-glasgow.aspx